| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.009 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |